Us Biotech Firm Moderna
- All
- News
- Videos
-
Moderna Seeks US Approval For Covid Vaccine For Children Under 6
US biotech firm Moderna said Thursday it had submitted a request for an emergency use authorization in the United States for its Covid vaccine for children aged six months to under six years.
-
Infant Covid Vaccine Succeeded In Trial, Says Moderna
US biotech firm Moderna on Wednesday said it was pursuing regulatory approval for its Covid vaccine in children aged six months to six years after the two-shot regimen was found to be safe and produced a strong immune response.
-
HIV Vaccine Tests Using mRNA Technology Begin In US
Testing in humans of an HIV vaccine that uses messenger RNA technology has begun, the biotech firm Moderna and the International AIDS Vaccine Initiative said Thursday.
-
US Delays Approval For Moderna Covid Vaccine In Teenagers
US biotech firm Moderna said Sunday that American officials have delayed approving its COVID-19 vaccine for teenagers to allow more time to better assess the potential risk of developing myocarditis, or heart inflammation.
-
Moderna Seeks Approval Of Covid Vaccine For Teens In Europe, Canada
US biotech firm Moderna said Monday it was seeking conditional approval for use of its Covid-19 vaccine on teens in Europe and Canada, in what will assuredly be a boost for inoculation campaigns.
-
Moderna Says Covid Vaccine "Highly Effective" In Adolescents
US biotech firm Moderna said Tuesday that trials had shown its Covid-19 vaccine is "highly effective" in adolescents aged 12-17 and the company would seek regulators' approval in June.
-
South African Variant-Specific Vaccine Ready For Testing: Moderna
US biotech firm Moderna said Wednesday that doses of its new Covid-19 vaccine candidate aimed at the South African coronavirus variant had been shipped to the US National Institutes of Health for testing.
-
Moderna's Coronavirus Vaccine Won't Be Ready Before US Elections: Report
US biotech firm Moderna won't seek an emergency use authorization for its coronavirus vaccine before November 25, its CEO told the Financial Times on Wednesday.
-
Moderna, Pfizer Share Covid Vaccine Trial Blueprints Amid Pressure
US biotech firm Moderna, one of nine companies in the late stages of clinical trials for a Covid-19 vaccine, became the first to publish the complete blueprints of its study following calls for greater transparency.
-
China Rejects Accusations Of Hacking Attempt On US COVID-19 Vaccine Firm Moderna
China rejected on Friday charges that hackers linked to its government targeted biotech firm Moderna Inc, a leading US-based coronavirus vaccine research developer, to steal data.
-
Moderna's COVID-19 Vaccine Worked Well In Monkeys: Study
US biotech firm Moderna's COVID-19 vaccine induced a robust immune response and prevented the coronavirus from replicating in the noses and lungs of monkeys, a study in the New England Journal of Medicine said Tuesday.
-
US COVID-19 Vaccine Enters Final Stage Trial This Month
The US biotech firm Moderna said Tuesday it would enter the final stage of human trials for its COVID-19 vaccine on July 27, after promising early results were published in an influential journal.
-
Moderna Seeks US Approval For Covid Vaccine For Children Under 6
US biotech firm Moderna said Thursday it had submitted a request for an emergency use authorization in the United States for its Covid vaccine for children aged six months to under six years.
-
Infant Covid Vaccine Succeeded In Trial, Says Moderna
US biotech firm Moderna on Wednesday said it was pursuing regulatory approval for its Covid vaccine in children aged six months to six years after the two-shot regimen was found to be safe and produced a strong immune response.
-
HIV Vaccine Tests Using mRNA Technology Begin In US
Testing in humans of an HIV vaccine that uses messenger RNA technology has begun, the biotech firm Moderna and the International AIDS Vaccine Initiative said Thursday.
-
US Delays Approval For Moderna Covid Vaccine In Teenagers
US biotech firm Moderna said Sunday that American officials have delayed approving its COVID-19 vaccine for teenagers to allow more time to better assess the potential risk of developing myocarditis, or heart inflammation.
-
Moderna Seeks Approval Of Covid Vaccine For Teens In Europe, Canada
US biotech firm Moderna said Monday it was seeking conditional approval for use of its Covid-19 vaccine on teens in Europe and Canada, in what will assuredly be a boost for inoculation campaigns.
-
Moderna Says Covid Vaccine "Highly Effective" In Adolescents
US biotech firm Moderna said Tuesday that trials had shown its Covid-19 vaccine is "highly effective" in adolescents aged 12-17 and the company would seek regulators' approval in June.
-
South African Variant-Specific Vaccine Ready For Testing: Moderna
US biotech firm Moderna said Wednesday that doses of its new Covid-19 vaccine candidate aimed at the South African coronavirus variant had been shipped to the US National Institutes of Health for testing.
-
Moderna's Coronavirus Vaccine Won't Be Ready Before US Elections: Report
US biotech firm Moderna won't seek an emergency use authorization for its coronavirus vaccine before November 25, its CEO told the Financial Times on Wednesday.
-
Moderna, Pfizer Share Covid Vaccine Trial Blueprints Amid Pressure
US biotech firm Moderna, one of nine companies in the late stages of clinical trials for a Covid-19 vaccine, became the first to publish the complete blueprints of its study following calls for greater transparency.
-
China Rejects Accusations Of Hacking Attempt On US COVID-19 Vaccine Firm Moderna
China rejected on Friday charges that hackers linked to its government targeted biotech firm Moderna Inc, a leading US-based coronavirus vaccine research developer, to steal data.
-
Moderna's COVID-19 Vaccine Worked Well In Monkeys: Study
US biotech firm Moderna's COVID-19 vaccine induced a robust immune response and prevented the coronavirus from replicating in the noses and lungs of monkeys, a study in the New England Journal of Medicine said Tuesday.
-
US COVID-19 Vaccine Enters Final Stage Trial This Month
The US biotech firm Moderna said Tuesday it would enter the final stage of human trials for its COVID-19 vaccine on July 27, after promising early results were published in an influential journal.
